Freestone Grove Partners »

Evommune shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.8M 337k 22.99

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune